Actively Recruiting
Neurofeedback-based Visual Restoration Therapy
Led by Adrian Guggisberg · Updated on 2026-04-29
14
Participants Needed
2
Research Sites
127 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Visual field defects are a common consequence of acquired brain injuries and affect people of all ages. These vision problems make everyday life more difficult-for example, when reading, driving, or moving around safely. However, there is currently no effective therapy to improve visual field defects. Previous training methods have focused on maximizing brain activity during a task. However, new findings show that the best performance is achieved when the brain is already in a state of high communication before the task. Our research shows that people can learn to increase communication between brain regions through neurofeedback. Studies have shown that neurofeedback can help people after a stroke: it improves the coordination of brain areas that are important for movement, thereby helping to increase mobility. Building on these findings, this study investigates whether EEG neurofeedback can support the visual centers in the brain to improve vision in patients with chronic visual field defects. The main objective of the study is to evaluate the effectiveness of neurofeedback in improving visual field defects. More specifically, the investigators are investigating the development of visual ability (expansion of the visual field, contrast sensitivity).
CONDITIONS
Official Title
Neurofeedback-based Visual Restoration Therapy
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Chronic, stable homonymous visual field defects (lateral quadranopsia or hemianopsia)
- Stroke occurred 12 months or more before enrollment
- Age between 50 and 70 years
- Ability to provide informed consent
You will not qualify if you...
- Inability to concentrate during long treatment sessions
- Eye disease affecting visual field or visual acuity
- Presence of non-MRI safe metal in the body
- New stroke during the study period
- Hemispatial neglect
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
Inselspital
Bern, Canton of Bern, Switzerland, 3010
Actively Recruiting
2
Division of Neurorehabilitation, University Hospital of Geneva
Geneva, Canton of Geneva, Switzerland, 1202
Not Yet Recruiting
Research Team
A
Adrian Guggisberg, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
CROSSOVER
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here